Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema

Figure 1

Changes in the mean best-corrected visual acuity (BCVA) expressed in logarithm of the minimum angle of resolution (logMAR) units before and after IVA and IVR treatment in eyes with (SRD+) and without (SRD−) a serous retinal detachment. After 6 months of IVA treatment, the BCVA is significantly improved from the baseline, but after 6 months after IVR, the effectiveness of improvement of BCVA does not persist. Data are expressed as the mean ± SEM. ; relative to the baseline of the BCVA. SRD, serous retinal detachment; IVR, intravitreal ranibizumab injection; IVA, intravitreal aflibercept injection.